LGND
Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated 13F Holders
LGND Stock Ownership Activity
- # of activities:
- 1
- AVG reported price*:
- $113.68
- Current price*:
- +165.50%($301.82)
1 value investing guru has made changes to the Ligand Pharmaceuticals Incorporated (LGND) position according to the gurus' 2025 Q2 SEC quarterly report(s). LGND has been bought (as a new position) by 1 guru(s)
Which gurus or hedge funds bought LGND in 2025 Q2?
According to the 2025 Q2 SEC filing(s) Ligand Pharmaceuticals Incorporated (LGND) has been bought by Tweedy, Browne Co All Funds (US) (new buy).
To see more about who is investing in Ligand Pharmaceuticals Incorporated (LGND), please go to the LGND ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.